Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCP1004 vs RLD2401 in chronic low-back pain
NCT06595004Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of NAXOZOL in chronic low back pain (CLBP), sponsored by Hanmi Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
NAXOZOL
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT06595004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06595004.